Oritavancin for Treatment of Serious Cardiac Infections

Clinical trial NCT07550595 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07550595
Sponsor: Kirby Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Infective Endocarditis Cardiac Device Infection Gram-positive Bacterial Infections

Start date: 2026-07-01
Primary completion: 2028-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.